DAVID S FOLLOWILL to Leukemia P388
This is a "connection" page, showing publications DAVID S FOLLOWILL has written about Leukemia P388.
Connection Strength
0.006
-
Assessment of pulmonary and hematologic toxicities of liblomycin, a novel bleomycin analog. Invest New Drugs. 1990 Feb; 8(1):33-41.
Score: 0.006
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.